Skip to main content
OpenTrials
Completed

NCT Number: NCT04555200

Continuous Enteral Rehydration by Nasogastric Tube With ORS in Children With Acute Gastroenteritis

When oral rehydration is impossible, enteral rehydration via the nasogastric route has been the recommended method of rehydration since 2008 by ESPGHAN ( European Society for Paediatric Gastroenterology Hepatology and Nutrition ), for children with acute gastroenteritis. However, these recommendations are rarely followed in France. These recommendations were not applied in the Children's Emergency Department of BREST University Hospital. The investigators changed the protocol and shared it with the caregivers of the emergency unit. The investigators studied the impact of this change of protocol

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 day–15 year

Sex eligibility

All sexes

Study type

Observational

Primary location

CHRU de Brest (urgences pédiatriques)

Brest, France

About this study

The main purpose was to assess the proportion of children rehydrated by nasogastric tube(NG) after protocol change. Secondary outcomes were to assess hospital length of stay and sides effects.

It is a retro and prospective study. The first phase took place from June to September 2018 and the second from June to September 2019. Any child presenting to pediatric emergencies for acute gastroenteritis requiring nonoral rehydration was included.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Any child presenting to pediatric emergencies for acute gastroenteritis requiring nonoral rehydration was included

Exclusion criteria

  • acute gastroenteritis on return from tropical countries
  • child with endocrine system diseases requiring parenteral rehydration
  • history of chronic pathology requiring enteral feeding

Treatment and study plan

Primary outcomes

  1. Number of nasogastric tube after changing gastroenteritis rehydration protocol

    Time frame: 4 months

    assessed by the number of NG tube and IV in each group

Secondary outcomes

  1. Hospital lenght of stay between each group

    Time frame: 4 months

    evaluate by administrative data of each case (arrival time and departure time)

  2. Number of Participants With Treatment-Related Adverse Events for each method

    Time frame: 4 months

    Serious sides effect were death and epilptic seizure. Mild sides effects were multiple (IV or NG ripped out, vomiting, failure...).

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Official study title

Continuous Enteral Rehydration by Nasogastric Tube With ORS in Children With Acute Gastroenteritis: Evaluation of Professional Practices Before and After Protocol Change

Acronym: GEA

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Sep 18, 2020
Registry last updated
Sep 18, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.